Collectively, the studies underscore the complexity of androgen signaling, senescence regulation, and immune evasion in PCa, offering novel targets such as H2AJ, MIR503HG, ARv7/SKP2, and VDAC for combination therapies to improve treatment outcomes. This evidence concerns the gene SKP2 and posterior cortical atrophy.